2022
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study
Probert W, Sauter R, Pickles M, Cori A, Bell-Mandla N, Bwalya J, Abeler-Dörner L, Bock P, Donnell D, Floyd S, Macleod D, Piwowar-Manning E, Skalland T, Shanaube K, Wilson E, Yang B, Ayles H, Fidler S, Hayes R, Fraser C, Team H, Hayes R, Fidler S, Beyers N, Ayles H, Bock P, El-Sadr W, Cohen M, Eshleman S, Agyei Y, Piwowar-Manning E, Bond V, Hoddinott G, Donnell D, Floyd S, Wilson E, Emel L, Noble H, Macleod D, Burns D, Fraser C, Cori A, Sista N, Griffith S, Moore A, Headen T, White R, Miller E, Hargreaves J, Hauck K, Thomas R, Limbada M, Bwalya J, Pickles M, Sabapathy K, Schaap, Dunbar R, Shanaube K, Yang B, Simwinga M, Smith P, Vermund S, Mandla N, Makola N, van Deventer A, James A, Jennings K, Kruger J, Phiri M, Kosloff B, Mwenge L, Kanema S, Sauter R, Probert W, Kumar R, Sakala E, Silumesi A, Skalland T, Yuhas K. Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study. The Lancet HIV 2022, 9: e771-e780. PMID: 36332654, PMCID: PMC9646978, DOI: 10.1016/s2352-3018(22)00259-4.Peer-Reviewed Original ResearchConceptsStandard of careHome-based testingCluster-randomised trialHigh-prevalence communitiesHIV incidenceHIV epidemicNational guidelinesNational InstituteUniversal testingHIV care cascadeAntiretroviral therapy uptakeUS President's Emergency PlanGeneralised HIV epidemicPresident's Emergency PlanPopART interventionCare cascadeART eligibilityArm BTherapy uptakeTrial interventionTrial dataInfectious diseasesAIDS ReliefIntervention impactDrug abuse
2017
Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial
Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith P, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K, Team H, Hargreaves J, Watson-Jones D, Godfrey-Faussett P, Cori A, Pickles M, Mandla N, Yang B, James A, Vermaak R, Makola N, Hoddinott G, Naidoo V, Bond V, Simwinga M, Mwinga A, Kosloff B, Limbada M, Bwalya J, Ngulube C, Fraser C, Eshleman S, Agyei Y, Cummings V, Catalano D, Emel L, Bunts L, Noble H, Burns D, Kouda A, Sista N, Moore A, White R, Headen T, Miller E, Hinson K, Vermund S, Barnes M, Horn L, Mwango A, Baldwin M, Wolf S, Hughes E. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial. The Lancet Global Health 2017, 5: e1133-e1141. PMID: 28964756, PMCID: PMC5640509, DOI: 10.1016/s2214-109x(17)30367-4.Peer-Reviewed Original ResearchConceptsHIV-negative peopleHIV-positive individualsHIV-negative individualsAntiretroviral therapyHealth-related qualityHIV careHRQoL scoresHIV statusHerpes simplex virus type-2 statusNational InstituteHPTN 071 (PopART) studyHPTN 071 (PopART) trialLaboratory-confirmed HIVType 2 statusCross-sectional baseline surveyLarge cross-sectional surveyRecreational drug useCross-sectional surveyPresident's Emergency PlanGeneral population sampleHRQoL informationBetter HRQoLHIV-negativeHIV progressionHRQoL data
2016
The National Institutes of Health Fogarty International Center Global Health Scholars and Fellows Program: Collaborating Across Five Consortia to Strengthen Research Training.
Zunt JR, Chi BH, Heimburger DC, Cohen CR, Strathdee S, Hobbs N, Thomas Y, Bale K, Salisbury K, Hernandez MT, Riley LW, Vermund SH, van der Horst C. The National Institutes of Health Fogarty International Center Global Health Scholars and Fellows Program: Collaborating Across Five Consortia to Strengthen Research Training. American Journal Of Tropical Medicine And Hygiene 2016, 95: 728-34. PMID: 27382074, PMCID: PMC5014285, DOI: 10.4269/ajtmh.16-0190.Peer-Reviewed Original Research
2014
Recruiting Post-Doctoral Fellows into Global Health Research: Selecting NIH Fogarty International Clinical Research Fellows
Heimburger DC, Warner TL, Carothers CL, Blevins M, Thomas Y, Gardner P, Primack A, Vermund SH. Recruiting Post-Doctoral Fellows into Global Health Research: Selecting NIH Fogarty International Clinical Research Fellows. American Journal Of Tropical Medicine And Hygiene 2014, 91: 219-224. PMID: 24865678, PMCID: PMC4125240, DOI: 10.4269/ajtmh.13-0741.Peer-Reviewed Original ResearchConceptsDisease ProjectClinical researchCharacteristics of enrolleesInternational clinical researchHealth professionalsClinical fellowshipNIH institutesNational InstituteHealth researchGlobal health researchMedical degreeInternational fellowsApplicant competitivenessEnrolleesFellowsResearch trainingWomen
2011
Nurturing the Global Workforce in Clinical Research: The National Institutes of Health Fogarty International Clinical Scholars and Fellows Program
Heimburger DC, Carothers CL, Gardner P, Primack A, Warner TL, Vermund SH. Nurturing the Global Workforce in Clinical Research: The National Institutes of Health Fogarty International Clinical Scholars and Fellows Program. American Journal Of Tropical Medicine And Hygiene 2011, 85: 971-978. PMID: 22144429, PMCID: PMC3225173, DOI: 10.4269/ajtmh.2011.11-0141.Peer-Reviewed Original ResearchConceptsHealth research partnershipsChronic disease researchClinical research settingClinical trialsObservational studyGlobal health expertsClinical investigatorsInfectious diseasesClinical researchTranslational researchHealth expertsInternational investigatorsNational InstituteFogarty International Clinical Research ScholarsHealth researchClinical scholarsDisease researchGlobal health researchResearch settingsHigh-impact journalsInvestigatorsTraining opportunitiesDiseaseTrials
2010
Addressing Research Priorities for Prevention of HIV Infection in the United States
Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, Sadr W. Addressing Research Priorities for Prevention of HIV Infection in the United States. Clinical Infectious Diseases 2010, 50: s149-s155. PMID: 20397942, PMCID: PMC2862583, DOI: 10.1086/651485.Peer-Reviewed Original ResearchConceptsHIV infectionHuman immunodeficiency virusHispanic womenHIV Prevention Trials NetworkNew HIV infectionsClinical Trials GroupName-based reportingHigh rateImmunodeficiency virusAIDS diagnosisTrial groupUS womenInfected personsPrevention estimatesUS populationHealth messagesEthnic minority populationsTrials NetworkDisease controlInfectionWhite womenWomenPreventionNational InstituteMen
2008
Building Global Health Through a Center-Without-Walls: The Vanderbilt Institute for Global Health
Vermund SH, Sahasrabuddhe VV, Khedkar S, Jia Y, Etherington C, Vergara A. Building Global Health Through a Center-Without-Walls: The Vanderbilt Institute for Global Health. Academic Medicine 2008, 83: 154-164. PMID: 18303361, PMCID: PMC2564795, DOI: 10.1097/acm.0b013e318160b76c.Peer-Reviewed Original ResearchConceptsGlobal healthResource-limited settingsHealth sciences graduate studentsExtramural supportHealth servicesMedical careHealth encompassesClinical fellowsDisease controlSchool of MedicineHealth ProjectNational InstituteResearch training programsTropical MedicineHealth researchPublic healthVanderbilt InstituteHealthGlobal health researchInternational health projectsTraining programService initiativesMedicineCenterInstitute
1994
The role of prevention research in HIV vaccine trials.
Vermund SH. The role of prevention research in HIV vaccine trials. AIDS Research And Human Retroviruses 1994, 10 Suppl 2: s303-5. PMID: 7865326.Peer-Reviewed Original ResearchConceptsVaccine trialsLarge-scale vaccine trialsHIV vaccine efficacy trialsPrevention researchVaccine efficacy trialsHIV vaccine trialsPrevention clinical trialsHIV prevention researchSexual transmissionClinical trialsEfficacy trialsNeedle useHIV researchInfectious diseasesBlood contaminationPotential trial sitesTrialsNational InstituteObservational researchTrial sitesSame criteriaPrevention technologiesAllergyVaccineInfection
1992
CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review
Stein D, Korvick J, Vermund S. CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review. The Journal Of Infectious Diseases 1992, 165: 352-363. PMID: 1346152, DOI: 10.1093/infdis/165.2.352.Peer-Reviewed Original ResearchConceptsCell countHuman immunodeficiency virus (HIV) diseaseHuman immunodeficiency virus (HIV) infectionIntercurrent viral infectionPractical clinical perspectiveProgressive infectious processImmunodeficiency virus infectionImportant therapeutic decisionsAIDS CommentaryInfluence of drugsT helperClinical courseHIV infectionSurrogate markerTherapeutic decisionsVirus infectionInfectious processViral infectionCD4Clinical perspectiveEnd stageInfectionNational InstituteVirus diseaseCountRecent Scientific Contributions to Understanding HIV/AIDS from the Multicenter AIDS Cohort Study
Detels R, Phair J, Saah A, Rinaldo C, Murioz A, Kaslow R, Seminara D, Schrager L, Vermund S. Recent Scientific Contributions to Understanding HIV/AIDS from the Multicenter AIDS Cohort Study. Journal Of Epidemiology 1992, 2: 11. DOI: 10.2188/jea.2.2sup_11.Peer-Reviewed Original ResearchMulticenter AIDS Cohort StudyAIDS Cohort StudyCohort studyPublic healthPrincipal investigatorComprehensive cancer centerNational Cancer InstituteHIV/AIDSCancer CenterUniversity Medical SchoolCancer InstituteJohns Hopkins University SchoolInfectious diseasesJohns Hopkins SchoolPittsburgh Graduate SchoolNational InstituteUniversity SchoolHealthHygieneInvestigatorsUniversity of CaliforniaProject officersMedical schoolsAllergyAIDS